
Divinus
Divinusmet Xr, Dapagliflozin/Metformin, 5/1000 Mg - 60 Tablets
119.40
SKU: 106138
Product Description
Product Name
- Divinusmet XR, Dapagliflozin/Metformin, 5/1000 Mg - 60 Tablets
Scientific Name
- Dapagliflozin / Metformin
Category Of Divinusmet XR
- Combination Antidiabetic (SGLT2 Inhibitor + Biguanide)
Mechanism Of Action Of Dapagliflozin / Metformin
- Dapagliflozin inhibits sodium-glucose co-transporter 2 (SGLT2) in the kidneys, reducing glucose reabsorption and increasing its excretion in urine.
- Metformin reduces hepatic glucose production and improves insulin sensitivity, enhancing peripheral glucose uptake.
Therapeutic Indications Of Divinusmet XR
- Indicated for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control.
- Suitable for patients not adequately controlled on either dapagliflozin or metformin alone.
Method Of Administration Of Divinusmet XR
- Take orally once daily with food to minimize gastrointestinal side effects.
- Swallow tablets whole without crushing or chewing.
- Dose adjustments may be required based on renal function and individual response.
Undesirable Side Effects Of Divinusmet XR
May cause:
- Genital infections (e.g., fungal infections)
- Urinary tract infections
- Nausea
- Diarrhea
- Abdominal pain
- Flatulence
- Metallic taste
- Dehydration
Pregnancy & Breastfeeding Precaution While Taking Divinusmet XR
- Not recommended during pregnancy or breastfeeding.
- Use only if the potential benefits justify the potential risks to the fetus or infant.
Warnings & Special Precautions While Taking Divinusmet XR
- Assess renal function prior to initiation and regularly during therapy.
- Not for use in patients with type 1 diabetes or diabetic ketoacidosis.
- Use with caution in patients at risk of dehydration or lactic acidosis.
- Monitor for signs of urogenital infections and gastrointestinal symptoms.
Storage Conditions Of Divinusmet XR
- Store below 30°C in a dry place.
- Keep away from moisture and light.
- Keep out of reach of children.
Show more